Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06435429
Title A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Jazz Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Oncology Tucson - Wilmot RECRUITING Tucson Arizona 85711 United States Details
Rocky Mountain Cancer Centers RECRUITING Denver Colorado 80218 United States Details
Minnesota Oncology Hematology RECRUITING Coon Rapids Minnesota 55433 United States Details
Messino Cancer Center RECRUITING Asheville North Carolina 28806 United States Details
Oncology Hematology Care (OHC) RECRUITING Cincinnati Ohio 45226 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
Texas Oncology - Fort Worth RECRUITING Fort Worth Texas 76104 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
Virginia Oncology Associates, Sentara Health RECRUITING Norfolk Virginia 23502 United States Details
Blue Ridge Cancer Care RECRUITING Roanoke Virginia 24014 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field